- Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial. JAMA. 2014 Academic Article GET IT
Inhibition of mutant GNAQ signaling in uveal melanoma induces AMPK-dependent autophagic cell death.
Molecular cancer therapeutics.
Times cited: 34
- Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype. PloS one. 2012 Academic Article GET IT